Check out what’s clicking on FoxBusiness.com.
Key Market Takeaways:
- Strategic Market Penetration:The NBA partnership in Australia and Southeast Asia marks a significant geographical expansion for IM8, leveraging the NBA’s immense regional popularity to capture share in high-growth wellness markets, directly contributing to Prenetics Global Limited’s (NASDAQ: PRE) ambitious valuation goals.
- Celebrity & Athlete Endorsement Power:Co-founder David Beckham and endorsements from elite athletes like Giannis Antetokounmpo and Aryna Sabalenka are not just marketing ploys; they are potent drivers of brand credibility, consumer trust, and accelerated subscription uptake in the premium health supplement sector, differentiating IM8 in a crowded market.
- Valuation Uplift & Product Diversification:IM8’s rapid growth, underscored by its contribution to Prenetics’ market cap rebound from $40 million to nearly half a billion, signals strong investor confidence. Future product pipeline expansion into high-value categories like hydration and gummies positions IM8 for sustained revenue growth and market dominance against established competitors.
IM8, the premium health and longevity brand co-founded by global icon David Beckham, has significantly amplified its market presence and financial trajectory with a series of strategic endorsements and partnerships. The latest coup sees one of the basketball world’s most dominant figures, Miami Heat’s Giannis Antetokounmpo, throwing his weight behind the brand. This high-profile endorsement is now being strategically leveraged as the NBA officially names IM8 its nutrition partner across the burgeoning markets of Australia and Southeast Asia.
This multi-year collaboration, announced on Monday by the NBA and IM8 — a wholly owned subsidiary of Prenetics Global Limited (NASDAQ: PRE), a leading global health services company — designates IM8 as the official nutrition partner in Australia and eight key Southeast Asian markets, including Indonesia, Malaysia, Singapore, and the Philippines. This move is a clear indicator of IM8’s aggressive market expansion strategy and its intent to capitalize on the rapidly growing health and wellness sector in the APAC region.
CLICK HERE FOR MORE SPORTS COVERAGE ONFOXBUSINESS.COM
Two-time NBA champion Chris Bosh, legendary soccer star David Beckham and NBA executives pose for IM8 and NBA partnership. (IM8/NBA / Fox News)
The announcement, made in Hong Kong alongside Beckham, fellow IM8 co-founder Danny Yeung, NBA executives, and two-time NBA champion Chris Bosh, underscores the brand’s rapid ascent. It highlights how IM8 is not just attracting elite athletes but also securing partnerships with major sports leagues, signaling a powerful market validation for its product efficacy and brand appeal.
In an exclusive interview, Danny Yeung, co-founder and CEO of Prenetics, offered insights into this pivotal partnership and IM8’s remarkable journey. Yeung’s narrative, characteristic of a driven entrepreneur, reveals a deep understanding of market dynamics and product development. His background — from humble beginnings, dropping out of high school at 15, and starting as a telemarketer — frames IM8’s success as a testament to strategic vision and relentless execution.
“To be fair, the last three days in Singapore, I’ve given three talks, and I’m just having so much fun,” Yeung expressed, beaming with pride. “The opportunity I have to meet with amazing people, amazing entrepreneurs, amazing athletes like [F1 driver] Ollie Bearman. Monday, I was with David Beckham in Hong Kong. This weekend, I’m at F1 in the garage. It’s been a dream come true for me. As an immigrant kid going to the U.S. from nothing and someone that dropped out of high school at age 15 and my first job was a telemarketer – it’s been a dream.”
DAVID BECKHAM EXPLAINS WHY HIS BANK OF AMERICA SPORTS DEAL ISN’T YOUR TRADITIONAL SPONSORSHIP
Yeung’s journey, marked by an early foray into entrepreneurial ventures like selling baseball cards at age 12, instilled a profound understanding of market demand and product value. This foundation has been critical in steering IM8 to become the fastest-growing premium supplement brand ever recorded, having delivered over 50 million servings to date. Despite this meteoric rise, Yeung’s humility remains a guiding principle, influencing the brand’s consumer-centric approach and commitment to quality.
“I started working at age 12 selling baseball cards,” he said. “…I just loved sports at a young age like a lot of people. To be able to be with these sports individuals, it’s just amazing. I came from nothing, so I always knew I wanted to create my own destiny, and I had to work really hard and make really good products and be very strategic about it, too. So, again, everything I believe in terms of IM8 has been a culmination of all my learnings from even as a teenager and all my past entrepreneurial experiences from the past 20-plus years.”
IM8’s core value proposition lies in its scientific rigor and product innovation. Its flagship offering, Daily Ultimate Essentials, consolidates 90 clinically dosed ingredients into a single sachet, designed to replace 16 different supplements. This “all-in-one” solution is a key market differentiator, appealing to consumers seeking efficiency without compromising on comprehensive nutrition. Crucially, the product is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and devoid of artificial flavors, colors, or sweeteners — attributes that resonate strongly with both elite athletes and health-conscious consumers in a discerning market.
“The product itself, we have 90 ingredients clinically dosed – I think that’s key,” Yeung explained. “… We are a subscription-based business. So, if it doesn’t work, people aren’t going to continue to subscribe. Athletes, I can tell you, I have a plethora of athletes that are on the product, and we just can’t talk about it.” The subscription model not only ensures recurring revenue but also signifies strong customer lifetime value, a critical metric for investors evaluating consumer health brands.
The organic adoption by high-profile athletes further validates IM8’s market impact. U.S. Open tennis champion Aryna Sabalenka, for instance, proactively sought a partnership after experiencing positive results from the product for three months. This authentic endorsement speaks volumes in a market often saturated with paid sponsorships, demonstrating the product’s ability to deliver tangible benefits.
Giannis Antetokounmpo partnered with IM8, the premium health and longevity brand. (IM8 / Fox News)
David Beckham’s involvement as a co-founder, rather than merely an ambassador, underscores a deeper commitment and carries significant weight in the market. Yeung credits Beckham’s trust and vision during a challenging period for Prenetics. “To give David a lot of credit, when I met David, our market cap was $40 million. We went from $1 billion to a $40 million market cap. So, you know who your friends are when you go from $1 billion to $40 million, right? So, he could’ve easily said, ‘Oh s—, this is a sinking ship. I don’t want anything to do with Prenetics or Danny.’ But he chose to trust in us, and he’s been so amazing because number one – he loves the brand and the product. His parents take it. His bloodwork he tells me is the best. We’ve been able to grow from a $40 million market cap to almost half-a-billion right now in the last 18 months. That gives you his vision and insights.” This financial turnaround, powered significantly by IM8’s performance, highlights Beckham’s strategic business acumen and the brand’s strong market traction, boosting Prenetics’ valuation (NASDAQ: PRE) substantially.
“David said to me, ‘If we do this, Danny you have to promise me every product that we create has to be the best. Otherwise, I can’t put my name on it,’” Yeung recounted, emphasizing the commitment to premium quality that defines IM8 and differentiates it in a competitive landscape.
With Beckham’s influence, IM8 has attracted a constellation of global partners and ambassadors, including Antetokounmpo, Bearman, actress Lily Collins, and influential podcaster Jay Shetty. The NBA’s rigorous due diligence process, involving extensive vetting of ingredients, results, and certifications, further solidifies IM8’s credibility. “They studied all the ingredients, the results, the certifications and before any conversations took place, they made sure that they checked off every single ingredient and [certifications],” Yeung confirmed, validating the product’s scientific integrity.
Sir David Beckham, Co-owner of Inter Miami CF, reacts after the Campeones Cup 2026 match between Inter Miami CF and Cruz Azul at Nu Stadium on Sept. 16, 2026 in Miami, Florida.(Rich Storry – Leagues Cup/MLS / Getty Images)
GET FOX BUSINESS ON THE GO BY CLICKING HERE
The future looks robust for IM8 as it eyes expansion into other high-growth categories. Yeung hinted at an upcoming hydration product, directly taking aim at major players in the market. “It’s a huge category because Liquid IV does a billion-plus just in hydration, and I believe we have a better product than them in every fashion,” he stated, signaling aggressive competition. Furthermore, the brand plans to launch innovative gummies in the first half of 2027, with Yeung teasing a “secret weapon” that promises to disrupt the segment. This strategic pipeline expansion is critical for sustaining IM8’s growth momentum and diversifying its revenue streams.
Market Impact:
The NBA partnership in Australia and Southeast Asia represents a significant milestone for IM8 and its parent company, Prenetics Global Limited (NASDAQ: PRE). This strategic alliance is expected to substantially accelerate IM8’s revenue growth, particularly within high-potential APAC markets where both basketball and wellness industries are booming. For Prenetics, this translates into a bolstered valuation, further solidifying the recovery from its earlier market cap struggles and validating its investment in consumer health. The brand’s ability to attract and retain elite athlete endorsements, combined with a differentiated, scientifically-backed product, positions it as a formidable competitor in the fragmented premium supplement market. Investors will be closely watching IM8’s subscription growth rates and the successful execution of its product diversification strategy into categories like hydration and gummies, which promise to unlock substantial new revenue streams and challenge established billion-dollar brands. This aggressive market strategy, underpinned by strong celebrity backing and a commitment to quality, could set a new benchmark for brand building and market penetration in the global health and longevity sector, potentially influencing M&A activity and investment trends across the industry.